Evidence map›Paper›PMID 31767887›Full record

ArticleScientific reports2019

Ultrasensitive and label-free biosensor for the detection of Plasmodium falciparum histidine-rich protein II in saliva.

Gita V Soraya, Chathurika D Abeyrathne, Christelle Buffet, Duc H Huynh, Shah Mukim Uddin, Jianxiong Chan, Efstratios Skafidas, Patrick Kwan, Stephen J Rogerson

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Ultrasensitive ELISA for Accurate Detection ofOpen forum infectious diseases · 2025
    Article
  3. Article
  4. Urine and Saliva: Relevant Specimens for Malaria Diagnosis?Diagnostics (Basel, Switzerland) · 2022
    Review
  5. Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Gita V SorayaDepartment of Medicine, The University of Melbourne, Royal Melbourne Hospital, Victoria, 3050, Australia.
Chathurika D AbeyrathneDepartment of Medicine, The University of Melbourne, Royal Melbourne Hospital, Victoria, 3050, Australia.
Christelle BuffetDepartment of Medicine, The University of Melbourne, Royal Melbourne Hospital, Victoria, 3050, Australia.
Duc H HuynhCentre for Neural Engineering, The University of Melbourne, Carlton, VIC, 3053, Australia.
Shah Mukim UddinDepartment of Medicine, The University of Melbourne, Royal Melbourne Hospital, Victoria, 3050, Australia.
Jianxiong ChanDepartment of Medicine, The University of Melbourne, Royal Melbourne Hospital, Victoria, 3050, Australia.
Efstratios SkafidasCentre for Neural Engineering, The University of Melbourne, Carlton, VIC, 3053, Australia.ORCID http://orcid.org/0000-0003-4263-9972
Patrick KwanDepartment of Medicine, The University of Melbourne, Royal Melbourne Hospital, Victoria, 3050, Australia. patrick.kwan@monash.edu.
Stephen J RogersonDepartment of Medicine, The University of Melbourne, Royal Melbourne Hospital, Victoria, 3050, Australia. sroger@unimelb.edu.au.ORCID http://orcid.org/0000-0003-4287-1982
The Royal Melbourne Hospital · AUThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria elimination is a global public health priority. To fulfil the demands of elimination diagnostics, we have developed an interdigitated electrode sensor platform targeting the Plasmodium falciparum Histidine Rich Protein 2 (PfHRP2) protein in saliva samples. A protocol for frequency-specific PfHRP2 detection in phosphate buffered saline was developed, yielding a sensitivity of 2.5 pg/mL based on change in impedance magnitude of the sensor. This protocol was adapted and optimized for use in saliva with a sensitivity of 25 pg/mL based on change in resistance. Further validation demonstrated detection in saliva spiked with PfHRP2 from clinical isolates in 8 of 11 samples. With a turnaround time of ~2 hours, the label-free platform based on impedance sensors has the potential for miniaturization into a point-of-care diagnostic device for malaria elimination.

Indexed as

Antigens, ProtozoanBiosensing TechniquesDiagnostic Tests, RoutineElectric ImpedanceHumansMalaria, FalciparumMiniaturizationPlasmodium falciparumPoint-of-Care SystemsProtozoan ProteinsSalivaSensitivity and SpecificityAntigens, ProtozoanHRP-2 antigen, Plasmodium falciparumProtozoan Proteins

Identifiers

PMID31767887
PMCPMC6877566
OpenAlexW2991148820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.